PLEASE NOTE

Due to severe weather conditions in the Dallas area, The Dallas CVI symposium is being rescheduled to take place on January 18, 2014

DIRECTORS

  • Subhash Banerjee , MD, FACC, FSCAI
    Professor of Medicine
    University of Texas Southwestern Medical School
    Chief, Division of Cardiology
    Co-Director, Cardiac Catheterization Laboratories
    VA North Texas Health Care Systems
    Dallas, Texas
  • Emmanouil Brilakis , MD, PhD, FACC, FSCAI
    Professor of Medicine
    University of Texas Southwestern Medical School
    Director, Cardiac Catheterization Laboratories
    VA North Texas Health Care System
    Dallas, Texas

Symposium Overview

The goal of the 2016 Dallas Cardiovascular Innovations (Dallas CVI) Symposium is to highlight coronary, peripheral, structural, electrophysiologic and pharmacotherapy interventions that have reshaped the treatment of heart and vascular disease today. The focus of this scientific meeting is to bring the most innovative approved treatment options available for patients with cardiovascular disease to health care providers, not only in North Texas, but to a national and international audience. By inviting world renowned thought leaders in the field of cardiovascular medicine, Dallas CVI provides a unique platform for interactive and thoughtful discussions between healthcare providers, researchers and medical industry representatives on modalities to address the current gaps in our knowledgebase and treatment paradigms. The program will provide participants with in-depth education and state-of-the-art management information on how to optimally evaluate and treat patients with peripheral vascular disease, coronary artery disease, valvular heart disease, and arrhythmic heart disease.
 

EDUCATIONAL OBJECTIVES

Upon completion of this course, participants should be able to:

  • Establish the diagnosis of an acute coronary syndrome (ACS) and treat patients with ASC based on current guideline-based treatments strategies
  • Recognize different manifestations of patient presentation with peripheral artery disease (PAD), Identify high-risk subsets with lifestyle-limiting claudication and critical limb ischemia, and treat patients with PAD
  • Identify and treat patients with complex coronary artery, peripheral vascular, valve, or arrhythmic heart disease
  • Learn state-of-the-art management pearls for treating patients with hyperlipidemia, heart failure and valvular heart disease
  • Describe the guideline-based indications and best-practice recommendations for the use of hemodynamic support devices, intra-vascular imaging techniques, and physiologic assessment of intravascular hemodynamics, structural heart and antiarrythmic devices, antplatelet and antithrombotic drug interventions
     

TARGET AUDIENCE

The 2016 Dallas Cardiovascular Innovations Symposium has been designed to meet the needs of Interventional Cardiologists, Clinical Cardiologists, Internists, Residents, Fellows in Training, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists, and other Health Care providers and Investigators who participate in the management of patients with coronary, peripheral, structural, and arrhythmic cardivascular disease.

 

THE 2016 DALLAS CARDIOVASCULAR INNOVATIONS SYMPOSIUM 
IS DEDICATED TO THE MEMORY OF OWEN OBEL, MD